Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

TEDE per cumulated activity for family members exposed to adult patients treated with 131I.

Han EY, Lee C, Bolch WE.

Radiat Prot Dosimetry. 2013;153(4):448-56. doi: 10.1093/rpd/ncs128. Epub 2012 Jul 20.

PMID:
22821723
2.

Organ S values and effective doses for family members exposed to adult patients following I-131 treatment: a Monte Carlo simulation study.

Han EY, Lee C, Mcguire L, Brown TL, Bolch WE.

Med Phys. 2013 Aug;40(8):083901. doi: 10.1118/1.4812425.

PMID:
23927361
3.
4.

A practical guideline for the release of patients treated by I-131 based on Monte Carlo dose calculations for family members.

Han EY, Lee C, Mcguire L, Bolch WE.

J Radiol Prot. 2014 Jun;34(2):N7-17. doi: 10.1088/0952-4746/34/2/N7. Epub 2014 Apr 4.

PMID:
24705486
6.

Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.

Dewji S, Bellamy M, Hertel N, Leggett R, Sherbini S, Saba M, Eckerman K.

Med Phys. 2015 Apr;42(4):1851-7. doi: 10.1118/1.4915084.

PMID:
25832075
7.

A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy.

Siegel JA, Kroll S, Regan D, Kaminski MS, Wahl RL.

J Nucl Med. 2002 Mar;43(3):354-63.

9.
10.

Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131I.

Siegel JA, Marcus CS, Stabin MG.

Health Phys. 2007 Dec;93(6):667-77.

PMID:
17993847
11.

Assessment of the Point-Source Method for Estimating Dose Rates to Members of the Public from Exposure to Patients with 131I Thyroid Treatment.

Dewji SA, Bellamy M, Hertel N, Leggett R, Sherbini S, Saba M, Eckerman K.

Health Phys. 2015 Sep;109(3):233-41. doi: 10.1097/HP.0000000000000327. Erratum in: Health Phys. 2016 Mar;110(3):307.

PMID:
26222218
12.

3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.

Saeedzadeh E, Sarkar S, Abbaspour Tehrani-Fard A, Ay MR, Khosravi HR, Loudos G.

Radiat Prot Dosimetry. 2012 Jul;150(3):298-305. doi: 10.1093/rpd/ncr411. Epub 2011 Nov 7.

PMID:
22069233
13.

Hospital discharge of patients with thyroid carcinoma treated with 131I.

Venencia CD, Germanier AG, Bustos SR, Giovannini AA, Wyse EP.

J Nucl Med. 2002 Jan;43(1):61-5.

14.

Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members.

Rutar FJ, Augustine SC, Colcher D, Siegel JA, Jacobson DA, Tempero MA, Dukat VJ, Hohenstein MA, Gobar LS, Vose JM.

J Nucl Med. 2001 Jun;42(6):907-15.

15.

Calculations of S values and effective dose for the radioiodine carrier and surrounding individuals based on Chinese hybrid reference phantoms using the Monte Carlo technique.

Geng C, Tang X, Qian W, Guan F, Johns J, Yu H, Gong C, Shu D, Chen D.

J Radiol Prot. 2015 Sep;35(3):707-17. doi: 10.1088/0952-4746/35/3/707. Epub 2015 Sep 7.

PMID:
26344387
16.

Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.

Barrington SF, Kettle AG, O'Doherty MJ, Wells CP, Somer EJ, Coakley AJ.

Eur J Nucl Med. 1996 Feb;23(2):123-30. Erratum in: Eur J Nucl Med 1997 Dec;24(12):1545.

PMID:
8925845
17.

Consideration of the ICRP 2006 revised tissue weighting factors on age-dependent values of the effective dose for external photons.

Lee C, Lee C, Han EY, Bolch WE.

Phys Med Biol. 2007 Jan 7;52(1):41-58. Epub 2006 Dec 4.

PMID:
17183127
18.

Large-body radiation doses following radioiodine therapy.

Leslie WD, Havelock J, Palser R, Abrams DN.

Nucl Med Commun. 2002 Nov;23(11):1091-7.

PMID:
12411838
19.

Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.

Barrington SF, O'Doherty MJ, Kettle AG, Thomson WH, Mountford PJ, Burrell DN, Farrell RJ, Batchelor S, Seed P, Harding LK.

Eur J Nucl Med. 1999 Jul;26(7):686-92.

PMID:
10398815
20.

Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.

Jeong KH, Jung JW, Kim CB, Ahn BC, Lee HK, Yoo SJ, Day O, Lee JK.

Health Phys. 2014 Apr;106(4):466-74. doi: 10.1097/HP.0b013e3182a415eb.

PMID:
24562067
Items per page

Supplemental Content

Write to the Help Desk